Regenxbio Cash And Short Term Investments vs Short Term Investments Analysis

RGNX Stock

USD 7.30 0.02 0.27%

Regenxbio financial indicator trend analysis is much more than just breaking down Regenxbio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Regenxbio is a good investment. Please check the relationship between Regenxbio Cash And Short Term Investments and its Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regenxbio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Cash And Short Term Investments vs Short Term Investments

Cash And Short Term Investments vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Regenxbio Cash And Short Term Investments account and Short Term Investments. At this time, the significance of the direction appears to have strong relationship.

The correlation between Regenxbio's Cash And Short Term Investments and Short Term Investments is 0.71. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Regenxbio, assuming nothing else is changed. The correlation between historical values of Regenxbio's Cash And Short Term Investments and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Regenxbio are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Cash And Short Term Investments i.e., Regenxbio's Cash And Short Term Investments and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Regenxbio balance sheet. This account contains Regenxbio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Regenxbio fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Short Term Investments

Short Term Investments is an item under the current assets section of Regenxbio balance sheet. It contains any investments Regenxbio undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Regenxbio can easily liquidate in the marketplace.

Most indicators from Regenxbio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Regenxbio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regenxbio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.At this time, Regenxbio's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 1.49 in 2025, despite the fact that Tax Provision is likely to grow to (47 K).

	2022	2023	2024	2025 (projected)
Gross Profit	58.2M	53.0M	61.0M	91.4M
Total Revenue	112.7M	90.2M	103.8M	111.6M

Gross Profit Total Revenue

Regenxbio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Non Currrent Assets Other	Other Assets	Short Term Investments	Inventory
Total Assets		0.8	0.79	0.8	0.96	0.71	-0.49	-0.58	0.7	0.75	0.95	0.96	0.85	-0.64	0.88	0.72	0.85	0.86	0.97	0.69	-0.64	0.96	0.69	0.58	0.69	0.9
Short Long Term Debt Total	0.8		0.99	0.99	0.64	0.31	-0.08	-0.88	0.94	0.46	0.77	0.74	0.74	-0.48	0.79	0.96	0.92	0.98	0.77	0.83	-0.48	0.76	0.39	0.31	0.64	0.95
Other Current Liab	0.79	0.99		1.0	0.66	0.33	-0.04	-0.89	0.94	0.42	0.78	0.73	0.72	-0.49	0.81	0.99	0.94	0.95	0.75	0.79	-0.49	0.78	0.42	0.35	0.66	0.96
Total Current Liabilities	0.8	0.99	1.0		0.67	0.36	-0.03	-0.89	0.95	0.41	0.79	0.73	0.73	-0.49	0.81	0.98	0.94	0.95	0.76	0.81	-0.49	0.79	0.43	0.33	0.68	0.97
Total Stockholder Equity	0.96	0.64	0.66	0.67		0.81	-0.51	-0.44	0.57	0.7	0.92	0.93	0.76	-0.67	0.83	0.6	0.78	0.71	0.92	0.56	-0.67	0.96	0.77	0.59	0.67	0.81
Current Deferred Revenue	0.71	0.31	0.33	0.36	0.81		-0.5	-0.13	0.25	0.57	0.71	0.67	0.64	-0.57	0.59	0.26	0.48	0.39	0.67	0.31	-0.57	0.7	0.45	0.6	0.42	0.52
Net Debt	-0.49	-0.08	-0.04	-0.03	-0.51	-0.5		-0.27	0.19	-0.92	-0.41	-0.56	-0.44	0.24	-0.21	0.08	-0.06	-0.28	-0.53	0.1	0.24	-0.35	-0.29	-0.62	0.13	-0.21
Retained Earnings	-0.58	-0.88	-0.89	-0.89	-0.44	-0.13	-0.27		-0.95	-0.1	-0.5	-0.57	-0.61	0.49	-0.76	-0.9	-0.88	-0.78	-0.6	-0.81	0.49	-0.63	-0.32	0.06	-0.74	-0.82
Accounts Payable	0.7	0.94	0.94	0.95	0.57	0.25	0.19	-0.95		0.2	0.66	0.65	0.65	-0.49	0.79	0.94	0.93	0.87	0.68	0.9	-0.49	0.71	0.4	0.07	0.77	0.89
Cash	0.75	0.46	0.42	0.41	0.7	0.57	-0.92	-0.1	0.2		0.67	0.78	0.68	-0.39	0.49	0.3	0.4	0.63	0.77	0.24	-0.39	0.6	0.41	0.67	0.14	0.55
Non Current Assets Total	0.95	0.77	0.78	0.79	0.92	0.71	-0.41	-0.5	0.66	0.67		0.84	0.71	-0.54	0.79	0.72	0.78	0.81	0.84	0.66	-0.54	0.91	0.59	0.7	0.58	0.87
Cash And Short Term Investments	0.96	0.74	0.73	0.73	0.93	0.67	-0.56	-0.57	0.65	0.78	0.84		0.88	-0.68	0.88	0.64	0.83	0.82	1.0	0.65	-0.68	0.92	0.74	0.43	0.71	0.85
Net Receivables	0.85	0.74	0.72	0.73	0.76	0.64	-0.44	-0.61	0.65	0.68	0.71	0.88		-0.51	0.81	0.64	0.77	0.81	0.9	0.63	-0.51	0.8	0.53	0.31	0.68	0.78
Common Stock Total Equity	-0.64	-0.48	-0.49	-0.49	-0.67	-0.57	0.24	0.49	-0.49	-0.39	-0.54	-0.68	-0.51		-0.65	-0.45	-0.64	-0.48	-0.67	-0.56	1.0	-0.7	-0.48	-0.16	-0.55	-0.59
Common Stock Shares Outstanding	0.88	0.79	0.81	0.81	0.83	0.59	-0.21	-0.76	0.79	0.49	0.79	0.88	0.81	-0.65		0.76	0.92	0.79	0.9	0.74	-0.65	0.92	0.68	0.31	0.86	0.89
Other Current Assets	0.72	0.96	0.99	0.98	0.6	0.26	0.08	-0.9	0.94	0.3	0.72	0.64	0.64	-0.45	0.76		0.92	0.9	0.68	0.74	-0.45	0.75	0.38	0.31	0.65	0.94
Other Stockholder Equity	0.85	0.92	0.94	0.94	0.78	0.48	-0.06	-0.88	0.93	0.4	0.78	0.83	0.77	-0.64	0.92	0.92		0.88	0.85	0.79	-0.64	0.88	0.61	0.27	0.82	0.96
Total Liab	0.86	0.98	0.95	0.95	0.71	0.39	-0.28	-0.78	0.87	0.63	0.81	0.82	0.81	-0.48	0.79	0.9	0.88		0.84	0.78	-0.48	0.78	0.43	0.41	0.59	0.94
Total Current Assets	0.97	0.77	0.75	0.76	0.92	0.67	-0.53	-0.6	0.68	0.77	0.84	1.0	0.9	-0.67	0.9	0.68	0.85	0.84		0.67	-0.67	0.93	0.72	0.43	0.73	0.87
Short Term Debt	0.69	0.83	0.79	0.81	0.56	0.31	0.1	-0.81	0.9	0.24	0.66	0.65	0.63	-0.56	0.74	0.74	0.79	0.78	0.67		-0.56	0.66	0.37	0.0	0.77	0.75
Common Stock	-0.64	-0.48	-0.49	-0.49	-0.67	-0.57	0.24	0.49	-0.49	-0.39	-0.54	-0.68	-0.51	1.0	-0.65	-0.45	-0.64	-0.48	-0.67	-0.56		-0.7	-0.48	-0.16	-0.55	-0.59
Net Tangible Assets	0.96	0.76	0.78	0.79	0.96	0.7	-0.35	-0.63	0.71	0.6	0.91	0.92	0.8	-0.7	0.92	0.75	0.88	0.78	0.93	0.66	-0.7		0.74	0.51	0.78	0.89
Non Currrent Assets Other	0.69	0.39	0.42	0.43	0.77	0.45	-0.29	-0.32	0.4	0.41	0.59	0.74	0.53	-0.48	0.68	0.38	0.61	0.43	0.72	0.37	-0.48	0.74		0.21	0.74	0.54
Other Assets	0.58	0.31	0.35	0.33	0.59	0.6	-0.62	0.06	0.07	0.67	0.7	0.43	0.31	-0.16	0.31	0.31	0.27	0.41	0.43	0.0	-0.16	0.51	0.21		-0.06	0.47
Short Term Investments	0.69	0.64	0.66	0.68	0.67	0.42	0.13	-0.74	0.77	0.14	0.58	0.71	0.68	-0.55	0.86	0.65	0.82	0.59	0.73	0.77	-0.55	0.78	0.74	-0.06		0.7
Inventory	0.9	0.95	0.96	0.97	0.81	0.52	-0.21	-0.82	0.89	0.55	0.87	0.85	0.78	-0.59	0.89	0.94	0.96	0.94	0.87	0.75	-0.59	0.89	0.54	0.47	0.7

Click cells to compare fundamentals

Regenxbio Account Relationship Matchups

Regenxbio fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	708.2M	1.1B	833.3M	574.0M	660.1M	487.0M
Short Long Term Debt Total	72.7M	86.7M	94.8M	89.3M	102.7M	107.8M
Other Current Liab	62.2M	100.9M	89.4M	100.3M	115.3M	121.1M
Total Current Liabilities	81.4M	130.5M	130.4M	130.3M	149.8M	157.3M
Total Stockholder Equity	377.8M	764.3M	516.2M	311.7M	358.5M	348.3M
Net Debt	(265.8M)	(258.5M)	(2.2M)	54.8M	49.3M	51.8M
Retained Earnings	(289.1M)	(161.2M)	(441.6M)	(705.0M)	(634.5M)	(602.8M)
Accounts Payable	10.6M	11.4M	27.2M	22.8M	26.2M	27.5M
Cash	338.4M	345.2M	97.0M	34.5M	39.7M	37.7M
Non Current Assets Total	177.0M	595.1M	417.3M	239.0M	274.8M	200.1M
Cash And Short Term Investments	475.7M	457.4M	364.6M	275.3M	316.5M	255.6M
Net Receivables	43.0M	32.4M	28.1M	26.3M	30.3M	18.3M
Common Stock Shares Outstanding	37.3M	43.9M	43.2M	43.7M	50.3M	33.3M
Liabilities And Stockholders Equity	708.2M	1.1B	833.3M	574.0M	660.1M	487.0M
Other Current Assets	12.5M	28.9M	23.3M	33.4M	38.4M	40.3M
Other Stockholder Equity	667.2M	928.1M	973.1M	1.0B	1.2B	1.2B
Total Liab	330.4M	349.6M	317.1M	262.2M	301.6M	316.6M
Total Current Assets	531.2M	518.8M	416.0M	335.0M	385.2M	286.9M
Accumulated Other Comprehensive Income	(360K)	(2.6M)	(15.4M)	(4.4M)	(4.0M)	(3.8M)
Short Term Debt	5M	3.5M	12.0M	7.1M	8.1M	5.2M
Net Tangible Assets	450.2M	377.8M	764.3M	516.2M	593.6M	386.3M
Non Currrent Assets Other	9.9M	10.7M	9.9M	7.5M	8.7M	8.4M
Other Assets	10.0M	8.8M	1.1B	9.9M	11.4M	10.8M
Short Term Investments	137.3M	112.2M	267.7M	240.7M	276.8M	168.1M
Inventory	6.5M	10.5M	18.8M	13.9M	16.0M	16.8M
Long Term Investments	50.1M	394.2M	200.6M	38.9M	44.7M	42.5M
Property Plant Equipment	39.1M	56.5M	192.5M	206.8M	237.8M	249.7M
Other Liab	5.2M	178.8M	134.2M	97.8M	112.5M	58.5M
Property Plant And Equipment Net	120.3M	192.5M	206.8M	192.6M	221.5M	232.6M
Retained Earnings Total Equity	(83.0M)	(177.8M)	(289.1M)	(161.2M)	(145.1M)	(152.4M)
Non Current Liabilities Total	249.0M	219.1M	186.6M	132.0M	151.7M	99.8M
Capital Surpluse	592.6M	627.8M	667.2M	928.1M	1.1B	586.6M
Property Plant And Equipment Gross	120.3M	192.5M	206.8M	249.8M	287.3M	301.6M
Net Invested Capital	377.8M	764.3M	516.2M	311.7M	358.5M	489.0M
Net Working Capital	449.8M	388.4M	285.5M	204.7M	235.4M	331.4M
Capital Lease Obligations	72.7M	86.7M	94.8M	89.3M	102.7M	66.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Regenxbio Cash And Short Term Investments vs Short Term Investments Analysis

Cash And Short Term Investments vs Short Term Investments

Cash And Short Term Investments vs Short Term Investments Correlation Analysis

Correlation Coefficient

Cash And Short Term Investments

Short Term Investments

Regenxbio fundamental ratios Correlations

Regenxbio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Regenxbio fundamental ratios Accounts

Also Currently Popular

Additional Tools for Regenxbio Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Other Current Liab	+ 0.99	Short Long Term Debt Total
Total Current Liabilities	+ 0.99	Short Long Term Debt Total
Other Current Assets	+ 0.99	Other Current Liab

Accounts Payable	- 0.95	Retained Earnings
Cash	- 0.92	Net Debt
Other Current Assets	- 0.9	Retained Earnings
Retained Earnings	- 0.89	Total Current Liabilities
Retained Earnings	- 0.89	Other Current Liab
Other Stockholder Equity	- 0.88	Retained Earnings